-
1
-
-
0027468594
-
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
-
Legius E., Marchuk D.A., Collins F.S., et al. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3 (1993) 122-126
-
(1993)
Nat Genet
, vol.3
, pp. 122-126
-
-
Legius, E.1
Marchuk, D.A.2
Collins, F.S.3
-
2
-
-
30144442616
-
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications
-
Gottfried O.N., Viskochil D.H., Fults D.W., and Couldwell W.T. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 58 (2006) 1-16
-
(2006)
Neurosurgery
, vol.58
, pp. 1-16
-
-
Gottfried, O.N.1
Viskochil, D.H.2
Fults, D.W.3
Couldwell, W.T.4
-
3
-
-
0033924917
-
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain
-
Fahsold R., Hoffmeyer S., Mischung C., et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66 (2000) 790-818
-
(2000)
Am J Hum Genet
, vol.66
, pp. 790-818
-
-
Fahsold, R.1
Hoffmeyer, S.2
Mischung, C.3
-
4
-
-
15744396344
-
Neurofibromatosis 1: from lab bench to clinic
-
Ward B.A., and Gutmann D.H. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol 32 (2005) 221-228
-
(2005)
Pediatr Neurol
, vol.32
, pp. 221-228
-
-
Ward, B.A.1
Gutmann, D.H.2
-
5
-
-
0036700983
-
Genetics of neurofibromatosis 1 and the NF1 gene
-
Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 17 (2002) 562-570
-
(2002)
J Child Neurol
, vol.17
, pp. 562-570
-
-
Viskochil, D.1
-
6
-
-
0032859469
-
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1
-
Mashour G.A., Wang H.L., Cabal-Manzano R., et al. Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. J Investig Dermatol 113 (1999) 398-402
-
(1999)
J Investig Dermatol
, vol.113
, pp. 398-402
-
-
Mashour, G.A.1
Wang, H.L.2
Cabal-Manzano, R.3
-
7
-
-
4444299065
-
Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1
-
Mashour G.A., Driever P.H., Hartmann M., et al. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin Cancer Res 10 (2004) 5677-5683
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5677-5683
-
-
Mashour, G.A.1
Driever, P.H.2
Hartmann, M.3
-
8
-
-
7444247940
-
Evaluation of primary haemostasis in people with neurofibromatosis type 1
-
Favaloro E.J., Zafer M., Nair S.C., et al. Evaluation of primary haemostasis in people with neurofibromatosis type 1. Clin Lab Haematol 26 (2004) 341-345
-
(2004)
Clin Lab Haematol
, vol.26
, pp. 341-345
-
-
Favaloro, E.J.1
Zafer, M.2
Nair, S.C.3
-
9
-
-
20844461912
-
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids
-
Wang H., Clouthier S.G., Galchev V., et al. Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 4 (2005) 618-625
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 618-625
-
-
Wang, H.1
Clouthier, S.G.2
Galchev, V.3
-
10
-
-
0001644020
-
The human plasma proteome: history, character, and diagnostic prospects
-
Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1 (2002) 845-867
-
(2002)
Mol Cell Proteomics
, vol.1
, pp. 845-867
-
-
Anderson, N.L.1
Anderson, N.G.2
-
11
-
-
23944480893
-
Utilizing human blood plasma for proteomic biomarker discovery
-
Jacobs J.M., Adkins J.N., Qian W.J., et al. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 4 (2005) 1073-1085
-
(2005)
J Proteome Res
, vol.4
, pp. 1073-1085
-
-
Jacobs, J.M.1
Adkins, J.N.2
Qian, W.J.3
-
12
-
-
0036206101
-
Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis
-
Zuo X., and Speicher D.W. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2 (2002) 58-68
-
(2002)
Proteomics
, vol.2
, pp. 58-68
-
-
Zuo, X.1
Speicher, D.W.2
-
14
-
-
32944474357
-
New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tools
-
Wang P.W., Chang W.N., Lu C.H., et al. New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tools. Proteomics 6 (2006) 1029-1037
-
(2006)
Proteomics
, vol.6
, pp. 1029-1037
-
-
Wang, P.W.1
Chang, W.N.2
Lu, C.H.3
-
15
-
-
30144444853
-
Bioinformatic methods to exploit mass spectrometric data for proteomic applications
-
Chalkley R.J., Hansen K.C., and Baldwin M.A. Bioinformatic methods to exploit mass spectrometric data for proteomic applications. Methods Enzymol 402 (2005) 289-312
-
(2005)
Methods Enzymol
, vol.402
, pp. 289-312
-
-
Chalkley, R.J.1
Hansen, K.C.2
Baldwin, M.A.3
-
16
-
-
33744996070
-
Different immunoaffinity fractionation strategies to characterize the human plasma proteome
-
Gong Y., Li X., Yang B., et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J Proteome Res 5 (2006) 1379-1387
-
(2006)
J Proteome Res
, vol.5
, pp. 1379-1387
-
-
Gong, Y.1
Li, X.2
Yang, B.3
-
17
-
-
30744433642
-
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis
-
Ebert M.P., Korc M., Malfertheiner P., et al. Advances, challenges, and limitations in serum-proteome-based cancer diagnosis. J Proteome Res 5 (2006) 19-25
-
(2006)
J Proteome Res
, vol.5
, pp. 19-25
-
-
Ebert, M.P.1
Korc, M.2
Malfertheiner, P.3
-
18
-
-
0142055892
-
The role of fibrinogen and related fragments in tumour angiogenesis and metastasis
-
Staton C.A., Brown N.J., and Lewis C.E. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther 3 (2003) 1105-1120
-
(2003)
Expert Opin Biol Ther
, vol.3
, pp. 1105-1120
-
-
Staton, C.A.1
Brown, N.J.2
Lewis, C.E.3
-
19
-
-
0034669975
-
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
-
Palumbo J.S., Kombrinck K.W., Drew A.F., et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96 (2000) 3302-3309
-
(2000)
Blood
, vol.96
, pp. 3302-3309
-
-
Palumbo, J.S.1
Kombrinck, K.W.2
Drew, A.F.3
-
20
-
-
0034834329
-
Fibronectin, integrins, and growth control
-
Danen E.H., and Yamada K.M. Fibronectin, integrins, and growth control. J Cell Physiol 189 (2001) 1-13
-
(2001)
J Cell Physiol
, vol.189
, pp. 1-13
-
-
Danen, E.H.1
Yamada, K.M.2
-
21
-
-
27544493101
-
Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma
-
Dasgupta B., Yi Y., Hegedus B., et al. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 65 (2005) 9843-9850
-
(2005)
Cancer Res
, vol.65
, pp. 9843-9850
-
-
Dasgupta, B.1
Yi, Y.2
Hegedus, B.3
-
22
-
-
16844375160
-
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors
-
Dasgupta B., Yi Y., Hegedus B., et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res 65 (2005) 2755-2760
-
(2005)
Cancer Res
, vol.65
, pp. 2755-2760
-
-
Dasgupta, B.1
Yi, Y.2
Hegedus, B.3
-
23
-
-
0035745119
-
Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro
-
Bootle-Wilbraham C.A., Tazzyman S., Thompson W.D., et al. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis (Lond.) 4 (2001) 269-275
-
(2001)
Angiogenesis (Lond.)
, vol.4
, pp. 269-275
-
-
Bootle-Wilbraham, C.A.1
Tazzyman, S.2
Thompson, W.D.3
-
24
-
-
32344451001
-
The role of fibrin clot degradation products in the regulation of vital functions of PC-12 cells
-
Kalashnyk O.M., Petrova I., Platonova T.M., et al. The role of fibrin clot degradation products in the regulation of vital functions of PC-12 cells. Ukr Biohim Zh 77 (2005) 37-44
-
(2005)
Ukr Biohim Zh
, vol.77
, pp. 37-44
-
-
Kalashnyk, O.M.1
Petrova, I.2
Platonova, T.M.3
-
25
-
-
27344452904
-
Ovarian cancer, the coagulation pathway, and inflammation
-
Wang X., Wang E., Kavanagh J.J., et al. Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3 (2005) 25-45
-
(2005)
J Transl Med
, vol.3
, pp. 25-45
-
-
Wang, X.1
Wang, E.2
Kavanagh, J.J.3
-
26
-
-
33646246400
-
Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis
-
Caunt M., Hu L., Tang T., et al. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 66 (2006) 4125-4132
-
(2006)
Cancer Res
, vol.66
, pp. 4125-4132
-
-
Caunt, M.1
Hu, L.2
Tang, T.3
-
27
-
-
32344445402
-
The association between fibrinogen, von Willebrand factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer
-
Koh S.C., Khalil R., Lim F.K., et al. The association between fibrinogen, von Willebrand factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer. Clin Appl Thromb / Hemost 12 (2006) 3-8
-
(2006)
Clin Appl Thromb / Hemost
, vol.12
, pp. 3-8
-
-
Koh, S.C.1
Khalil, R.2
Lim, F.K.3
|